Risk factors for the development of bronchiectasis in patients with asthma

Abstract Though asthma and bronchiectasis are two different diseases, their coexistence has been demonstrated in many patients. The aim of the present study is to compare the characteristics of asthmatic patients with and without bronchiectasis and to assess risk factors for the development of this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Donghai Ma, María-Jesús Cruz, Iñigo Ojanguren, Christian Romero-Mesones, Diego Varona-Porres, Xavier Munoz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/05393de38d814776ae86050b052bd8a9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:05393de38d814776ae86050b052bd8a9
record_format dspace
spelling oai:doaj.org-article:05393de38d814776ae86050b052bd8a92021-11-28T12:18:21ZRisk factors for the development of bronchiectasis in patients with asthma10.1038/s41598-021-02332-w2045-2322https://doaj.org/article/05393de38d814776ae86050b052bd8a92021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02332-whttps://doaj.org/toc/2045-2322Abstract Though asthma and bronchiectasis are two different diseases, their coexistence has been demonstrated in many patients. The aim of the present study is to compare the characteristics of asthmatic patients with and without bronchiectasis and to assess risk factors for the development of this condition. Two hundred and twenty-four moderate-severe asthmatic patients were included. The severity of bronchiectasis was assessed by Reiff and FACED parameters. Logistic regression was used to identify independent factors associated with bronchiectasis. Bronchiectasis was identified in 78 asthma patients. In severe asthma patients, its prevalence was 56.9%. Bronchiectasis was defined as mild in81% of patients using modified Reiff criteria and in 74% using FACED criteria. Asthmatic patients with bronchiectasis had decreasing FEV1, FVC and FEV1/FVC (p = 0.002, 0.005 and 0.014 respectively), presented more frequent asthma exacerbations (p < 0.001) and worse asthma control (ACT 21 vs 16pts, p < 0.001). Factors independently associated with bronchiectasis were older age (42–65 years: OR, 3.99; 95% CI 1.60 to 9.95, P = 0.003; ≥ 65 years: OR, 2.91; 95% CI 1.06 to 8.04, P = 0.039), severe asthma grade (OR, 8.91; 95% CI 3.69 to 21.49; P < 0.001) and frequency of asthma exacerbations (OR, 4.43; 95% CI 1.78 to 11.05; P < 0.001). In patients with severe asthma, age of asthma onset (OR, 1.02; 95% CI 1.01 to 1.04; P = 0.015) and asthma exacerbations (OR, 4.88; 95% CI 1.98 to 12.03; P = 0.001) were independently associated with the development of bronchiectasis. The prevalence of bronchiectasis in severe asthmatic patients is high. Age of asthma onset and exacerbations were independent factors associated with the occurrence of bronchiectasis.Donghai MaMaría-Jesús CruzIñigo OjangurenChristian Romero-MesonesDiego Varona-PorresXavier MunozNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Donghai Ma
María-Jesús Cruz
Iñigo Ojanguren
Christian Romero-Mesones
Diego Varona-Porres
Xavier Munoz
Risk factors for the development of bronchiectasis in patients with asthma
description Abstract Though asthma and bronchiectasis are two different diseases, their coexistence has been demonstrated in many patients. The aim of the present study is to compare the characteristics of asthmatic patients with and without bronchiectasis and to assess risk factors for the development of this condition. Two hundred and twenty-four moderate-severe asthmatic patients were included. The severity of bronchiectasis was assessed by Reiff and FACED parameters. Logistic regression was used to identify independent factors associated with bronchiectasis. Bronchiectasis was identified in 78 asthma patients. In severe asthma patients, its prevalence was 56.9%. Bronchiectasis was defined as mild in81% of patients using modified Reiff criteria and in 74% using FACED criteria. Asthmatic patients with bronchiectasis had decreasing FEV1, FVC and FEV1/FVC (p = 0.002, 0.005 and 0.014 respectively), presented more frequent asthma exacerbations (p < 0.001) and worse asthma control (ACT 21 vs 16pts, p < 0.001). Factors independently associated with bronchiectasis were older age (42–65 years: OR, 3.99; 95% CI 1.60 to 9.95, P = 0.003; ≥ 65 years: OR, 2.91; 95% CI 1.06 to 8.04, P = 0.039), severe asthma grade (OR, 8.91; 95% CI 3.69 to 21.49; P < 0.001) and frequency of asthma exacerbations (OR, 4.43; 95% CI 1.78 to 11.05; P < 0.001). In patients with severe asthma, age of asthma onset (OR, 1.02; 95% CI 1.01 to 1.04; P = 0.015) and asthma exacerbations (OR, 4.88; 95% CI 1.98 to 12.03; P = 0.001) were independently associated with the development of bronchiectasis. The prevalence of bronchiectasis in severe asthmatic patients is high. Age of asthma onset and exacerbations were independent factors associated with the occurrence of bronchiectasis.
format article
author Donghai Ma
María-Jesús Cruz
Iñigo Ojanguren
Christian Romero-Mesones
Diego Varona-Porres
Xavier Munoz
author_facet Donghai Ma
María-Jesús Cruz
Iñigo Ojanguren
Christian Romero-Mesones
Diego Varona-Porres
Xavier Munoz
author_sort Donghai Ma
title Risk factors for the development of bronchiectasis in patients with asthma
title_short Risk factors for the development of bronchiectasis in patients with asthma
title_full Risk factors for the development of bronchiectasis in patients with asthma
title_fullStr Risk factors for the development of bronchiectasis in patients with asthma
title_full_unstemmed Risk factors for the development of bronchiectasis in patients with asthma
title_sort risk factors for the development of bronchiectasis in patients with asthma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/05393de38d814776ae86050b052bd8a9
work_keys_str_mv AT donghaima riskfactorsforthedevelopmentofbronchiectasisinpatientswithasthma
AT mariajesuscruz riskfactorsforthedevelopmentofbronchiectasisinpatientswithasthma
AT inigoojanguren riskfactorsforthedevelopmentofbronchiectasisinpatientswithasthma
AT christianromeromesones riskfactorsforthedevelopmentofbronchiectasisinpatientswithasthma
AT diegovaronaporres riskfactorsforthedevelopmentofbronchiectasisinpatientswithasthma
AT xaviermunoz riskfactorsforthedevelopmentofbronchiectasisinpatientswithasthma
_version_ 1718408057153650688